Cleared Traditional

PRORAD ATLAS ULTRAPORTABLE (K243473) - FDA 510(k) Clearance

Also marketed or referenced as:
PRORAD ATLAS ULTRAPORTABLE PLUS

Class II Radiology device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K243473 · Prognosys Medical Systems Private Limited · Radiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jul 2025
Decision
263d
Days
Class 2
Risk

K243473 is an FDA 510(k) clearance for the PRORAD ATLAS ULTRAPORTABLE. Classified as System, X-ray, Mobile (product code IZL), Class II - Special Controls.

Submitted by Prognosys Medical Systems Private Limited (Bengaluru, IN). The FDA issued a Cleared decision on July 29, 2025 after a review of 263 days - an extended review cycle.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.1720 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Radiology review framework, consistent with the majority of Class II 510(k) submissions.

View all Prognosys Medical Systems Private Limited devices

Submission Details

510(k) Number K243473 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 08, 2024
Decision Date July 29, 2025
Days to Decision 263 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
156d slower than avg
Panel avg: 107d · This submission: 263d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code IZL System, X-ray, Mobile
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.1720
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Consultant

IZiel Healthcare
Ankur Naik

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - IZL System, X-ray, Mobile

All 95
Devices cleared under the same product code (IZL) and FDA review panel - the closest regulatory comparables to K243473.
PROMO
K251443 · DRGEM Corporation · Aug 2025
HnX-P1, HnX-PB
K251223 · H&abyz Co., Ltd. · Aug 2025
REMEX Xcam6
K250597 · Remedi, Inc. · Jul 2025
INNOVISION-P5
K250750 · Dk Medical Systems Co., Ltd. · Jul 2025
Europa (Alternative: AiRTouch) portable X-ray system
K244049 · Livermoretech, Inc. · May 2025
!M1
K241980 · Solutions For Tomorrow AB · May 2025